Date of Original Release: December 20, 2023
Date of Expiration:  December 20, 2026
Estimated Time of Completion:  1 hour

Target Audience
Dermatologists and others involved in the delivery of dermatologic care.

Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.

Learning Objectives
Following participation in this activity, the learner should be able to:

• Choose how to successfully integrate telehealth into your practice by becoming familiar with scheduling models, platform features, and image collection/storage to optimize clinical workflow.
• Identify patients who are clinically appropriate for telehealth visits.
• Explain telemedicine formats to patients and inform patients of how to use teledermatology appropriately
• Prepare patients for a virtual visit and coach patients on how to take high-quality photos
• Optimizing the doctor-patient virtual encounter and prepare patients for what to do after a virtual visit
• Describe how to prepare for a successful telehealth visit and recall the steps to take to anticipate, avoid, handle, or mitigate common telehealth visit pitfalls.
• Identify the proper and specific billing practices and CPT codes for the various types of telehealth services (e.g., E/M services delivered remotely, physician-to-physician consultations, e-consults, virtual check-ins, and store-and-forward evaluation of images).

Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA PRA Credit Statement
The American Academy of Dermatology designates this Enduring Material for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Instructions to Claim Credit
To claim CME credit for this activity, the learner must complete the post-activity evaluation survey.

Planners and Authors

Neha Jariwala, MD, FAAD
Department of Dermatology
University of Pennsylvania
Philadelphia, PA

Elizabeth Jones, MD, FAAD
Department of Dermatology
Thomas Jefferson University Hospital
Philadelphia, PA

Veronica Rotemberg, MD, FAAD
Director, Dermatology Imaging Informatics Program
Memorial Sloan Kettering Cancer Center
New York, NY

Cory Simpson, MD, PhD, FAAD
Department of Dermatology
University of Washington
Seattle, WA

Apra Sood, MD, FAAD
Department of Dermatology
University of California
Davis, CA

Veena Vanchinathan, MD, FAAD
San Jose Medical Center
Kaiser Permanente
San Jose, CA

Jenny Wang, MD, FAAD
Los Angeles, CA

Reviewer

Olga Afanasiev, MD, PhD, FAAD
Sutter Health
Palo Alto Medical Foundation
Sunnyvale, CA

Staff

Oliva Barry, MPH
Manager, Practice Management
Rosemont, IL

Dustin Herlich, MA
Manager, Digital Learning
Rosemont, IL

Melinda Keske
Sr. Coordinator, Digital Learning
Rosemont, IL

Christine Presta
Director, Digital Learning
Rosemont, IL

Camilia Schawel
Instructional Designer
Rosemont, IL

All planners, speakers, reviewers, and staff for this activity have no relevant financial relationships with ineligible companies (formerly known as commercial interests).

Conflict Mitigation Statement
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content.

Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.

Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition. 

No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.

Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.